Clinical Trials Directory

Trials / Completed

CompletedNCT03059862

The Role of Dietary Tryptophan on Aryl Hydrocarbon Receptor Activation

The Role of Tryptophan on Aryl Hydrocarbon Receptor Activation: a Randomized, Double Blind, Placebo-controlled, Crossover Design Pilot Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
McMaster University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

This study evaluates the role of dietary L-tryptophan, an essential amino acid, in the activation of a specific cellular component: the aryl hydrocarbon receptor.

Detailed description

The Aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor implicated in a range of key cellular events. In the gut, AHR is crucial for maintaining intestinal barrier immune homeostasis. The physiology of the AHR, however, is not completely understood; its precise gut luminal activators and functional consequences are unknown. Some AHR ligands originate from the diet. Commensals play crucial roles in metabolizing tryptophan and other amino acids such as tyrosine, with the subsequent production of tryptophan metabolites. Previous studies show that inflammatory bowel disease (IBD) patients have impaired production of AHR agonists by the microbiota. Furthermore, dietary supplementation with tryptophan ameliorates clinical parameters of colitis in rodent models. Whether these findings translate into human pathophysiology has not been explored. In the present study, the investigators will evaluate the effect of high- versus low-tryptophan diet on AHR activation in healthy participants. Briefly, participants will be instructed to follow a standardized low-tryptophan diet and will be randomized to a 3-week L-tryptophan supplement or placebo. Later, after a 2-week washout period, participants will crossover to the other arm. In addition, the effect of tryptophan and microbiota-derived metabolites on AHR activation will be analyzed.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTL-tryptophan3 g/day of L-tryptophan added to the standardized low-tryptophan diet. Duration: 3 weeks.
DIETARY_SUPPLEMENTPlaceboA placebo will be added to the standardized low-tryptophan diet. Duration: 3 weeks.

Timeline

Start date
2017-11-01
Primary completion
2018-04-30
Completion
2018-06-30
First posted
2017-02-23
Last updated
2023-04-13

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03059862. Inclusion in this directory is not an endorsement.